Cancer Biotherapy And Radiopharmaceuticals

雜志介紹

Cancer Biotherapy And Radiopharmaceuticals雜志介紹

《Cancer Biotherapy And Radiopharmaceuticals》是一本以English為主的未開放獲取國際優秀期刊，中文名稱癌癥生物治療和放射性藥物，本刊主要出版、報道醫學-MEDICINE, RESEARCH & EXPERIMENTAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.4，最新CiteScore 指數為7.8。

本刊近期中國學者發表的論文主要有：

• Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis

  Author: Jin, Wenhua; Zhang, Hua; Li, Meng; Lin, Sen

• LncRNA IUR Is Downregulated in Gastric Carcinoma and Associated with Poor Survival

  Author: Ou, Rui; Liu, Xin

• Gene Silencing of Transcription Factor TEAD4 Inhibits Esophageal Cancer Cells by Regulating TCF7

  Author: He, Songlin; Gao, Ke; Mao, Long; Bhushan, Sandeep; Xiao, Zongwei

• Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen Chemotherapy

  Author: Zhang, Qian; Zhang, Qinghua; Yan, Hui; You, Yanjie; Cao, Juan; Wang, Wenfan; Zhao, Dan; Zhang, Xiaoxu; Wu, Jing; Chen, Zhiqiang; Yang, Wenjun

英文介紹

Cancer Biotherapy And Radiopharmaceuticals雜志英文介紹

Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.